Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
8f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.726
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.594
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.797
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
8f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.811
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Triglycerides
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.498
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.807
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
8f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.615
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.274
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0531
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.551
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
2.74×10-05
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.144
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat Production (Metabolic Rate)
|
HOM
|
f:431m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:431m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
10f:20m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
25f:15m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0211
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.379
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0925
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.841
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.435
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.868
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0106
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
5f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.978
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.133
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.980
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0476
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.722
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
DEXA / Fat/Body weight
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0749
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0359
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.940
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0769
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.449
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0918
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.141
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
DEXA / Fat mass
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000100
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.117
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Carbon dioxide production
|
HOM
|
58f:465m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0667
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.443
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Oxygen consumption
|
HOM
|
58f:465m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000125
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.876
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Heat production (metabolic rate)
|
HOM
|
58f:465m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.267
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.736
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.720
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00140
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.245
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.832
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.127
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.605
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.887
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.298
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.224
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.478
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
4.31×10-05
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.163
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.273
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.392
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.401
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
2f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.506
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
5f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.900
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.151
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.964
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.661
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.822
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Dexa-scan analysis / Fat Mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.185
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00295
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.241
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
5f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.275
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.689
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.231
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.996
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Cumulative food intake
|
HOM
|
58f:407m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.794
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0571
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.286
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.298
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.628
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.210
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.834
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.391
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.219
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.430
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
4.65×10-05
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.195
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.438
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.167
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
2f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.392
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Dysmorphology / Body fat distribution
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
168f:431m
|
|
|
NotProcessed |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
5f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.362
|
Successful |
Wdr47tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.371
|
Successful |